Skip to NavigationSkip to content

News

0
Professor Paul Workman image
Leading expert calls for major changes to restock pipeline with innovative cancer treatments 
0
Lilly image
US firm admitted 2014 would be difficult but sales drop worse than expected
0
MRC image
British charities led by the Medical Research Council to fund cancer and dementia R&D
0
Viiv image
The jointly-owned HIV and AIDS business could be floated on the stock market 

Features

Bing image

Senior VP, R&D, respiratory, inflammation & autoimmunity iMED head talks to Pharmafile